Home › Asset managers › Compare 2025-2026 › TIAA vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
TIAA 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 58,772 | 44,349 | 3,418 | 11,005 | 92.8% | 87.0% |
| Board proposals | 49,673 | 36,224 | 3,273 | 10,176 | 91.7% | 85.7% |
| E&S shareholder proposals | 173 | 0 | 1 | 172 | 0.0% | 38.4% |
| Other items | 8,926 | 8,125 | 144 | 657 | 98.3% | 94.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
11,005 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | TIAA | Brighthouse |
|---|---|---|---|---|---|---|
| AMERICAN WATER WORKS COMPANY, INC. | May 13, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 5 FOR, 1 AGAINST, 3 ABSTAIN |
| AMERICAN WATER WORKS COMPANY, INC. | May 13, 2026 | Ratification of the appointment, by the Audit, Finance and Risk Committee of the Board of Directors, of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 7 funds |
Split 5 FOR, 1 AGAINST, 3 ABSTAIN |
| AMERICOLD REALTY TRUST, INC. | May 18, 2026 | Advisory Vote on Compensation of Named Executive Officers (Say-On-Pay). Say-on-Pay |
Board | For | FOR 5 funds |
Split 1 FOR, 1 ABSTAIN |
| AMERICOLD REALTY TRUST, INC. | May 18, 2026 | Ratification of Ernst & Young LLP as our Independent Accounting Firm for 2026. Audit-related |
Board | For | FOR 5 funds |
Split 1 FOR, 1 ABSTAIN |
| AMERICOLD REALTY TRUST, INC. | May 18, 2026 | To elect ten directors to hold office until the Annual Meeting of Stockholders to be held in 2027 and until their successors are duly elected and qualified. Robert S. Chambers Director Elections |
Board | For | FOR 5 funds |
Split 1 FOR, 1 ABSTAIN |
| AMERIPRISE FINANCIAL, INC. | April 29, 2026 | To approve the compensation of the named executive officers by a nonbinding advisory vote. Say-on-Pay |
Board | For | FOR 19 funds |
Split 6 FOR, 2 ABSTAIN |
| AMERIPRISE FINANCIAL, INC. | April 29, 2026 | To ratify the Audit and Risk Committee's appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 18 funds |
Split 6 FOR, 2 ABSTAIN |
| AMERIS BANCORP | May 21, 2026 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 5 FOR, 1 ABSTAIN |
| AMERIS BANCORP | May 21, 2026 | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 5 FOR, 1 ABSTAIN |
| AMETEK, INC. | May 7, 2026 | Approval, by advisory vote, of the compensation of AMETEK, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
Split 8 FOR, 3 ABSTAIN |
| AMETEK, INC. | May 7, 2026 | Election of Directors for a term of three years: Anthony J. Conti Director Elections |
Board | For | FOR 8 funds |
Split 7 FOR, 3 ABSTAIN |
| AMETEK, INC. | May 7, 2026 | Election of Directors for a term of three years: Gretchen W. McClain Director Elections |
Board | For | FOR 8 funds |
Split 7 FOR, 3 ABSTAIN |
| AMETEK, INC. | May 7, 2026 | Election of Directors for a term of three years: Thomas A. Amato Director Elections |
Board | For | FOR 8 funds |
Split 7 FOR, 3 ABSTAIN |
| AMETEK, INC. | May 7, 2026 | Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 8 funds |
Split 8 FOR, 3 ABSTAIN |
| AMGEN INC. | May 19, 2026 | Advisory vote to approve our executive compensation. Say-on-Pay |
Board | For | FOR 15 funds |
Split 8 FOR, 7 ABSTAIN |
| AMGEN INC. | May 19, 2026 | To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 14 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 8 funds |
Split 3 FOR, 1 ABSTAIN |
| AMKOR TECHNOLOGY, INC. | May 13, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 2 FOR, 3 ABSTAIN |
| AMKOR TECHNOLOGY, INC. | May 13, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 2 FOR, 3 ABSTAIN |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To approve Amendment No. 1 to the AMN Healthcare 2025 Equity Plan. Compensation |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To ratify the appointment of KPMG LLP to be our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Cary S. Grace Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Celia P. Huber Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Daphne E. Jones Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Eric P. Palmer Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: James H. Hinton Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Jorge A. Caballero Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Mark G. Foletta Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Teri G. Fontenot Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMNEAL PHARMACEUTICALS, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 2 FOR, 1 ABSTAIN |
| AMNEAL PHARMACEUTICALS, INC. | May 6, 2026 | Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026; and Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHENOL CORPORATION | May 21, 2026 | Advisory vote to approve compensation of named executive officers Say-on-Pay |
Board | For | FOR 12 funds |
Split 9 FOR, 1 AGAINST, 6 ABSTAIN |
| AMPHENOL CORPORATION | May 21, 2026 | Ratification of the selection of Deloitte & Touche LLP as independent public accountants Audit-related |
Board | For | FOR 11 funds |
Split 9 FOR, 1 AGAINST, 6 ABSTAIN |
| AMPLITUDE, INC. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPLITUDE, INC. | June 9, 2026 | The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPRIUS TECHNOLOGIES, INC. | June 11, 2026 | The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | Not determined | FOR 4 funds |
Split 1 FOR, 1 ABSTAIN |
| AMRIZE AG | April 21, 2026 | Re-election of Jan Jenisch as Chairman of the Board Corporate Governance |
Board | For | FOR 2 funds |
Split 2 FOR, 2 AGAINST |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
Split 1 FOR, 1 AGAINST, 1 ABSTAIN |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
Split 6 FOR, 1 AGAINST, 4 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Approve the Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 9 funds |
Split 7 FOR, 4 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year 2026. Audit-related |
Board | For | FOR 9 funds |
Split 6 FOR, 1 AGAINST, 4 ABSTAIN |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF MARTIN J. BARRINGTON AS RESTRICTED SHARE DIRECTOR AND ELECT WILLIAM F. GIFFORD, JR. AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF SALVATORE MANCUSO AS RESTRICTED SHARE DIRECTOR AND ELECT JENNIFER HUNTER AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | AUTHORIZE REPURCHASE OF UP TO 20 PERCENT OF ISSUED SHARE CAPITAL Capital Structure |
Board | For | FOR 3 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | REELECT ALEJANDRO SANTO DOMINGO AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Antonio R. Pera Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Jeanne A. Thoma Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Matthew J. Leonard, R.Ph. Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Muthusamy Shanmugam Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Nikhil Lalwani Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Renee P. Tannenbaum, Pharm.D. Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Thomas J. Haughey Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 2 ABSTAIN |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
| ANTERO MIDSTREAM CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Midstream Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 3 ABSTAIN |
| ANTERO MIDSTREAM CORPORATION | June 3, 2026 | To ratify the appointment of KPMG LLP as Antero Midstream Corporation's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 3 ABSTAIN |
| ANTERO RESOURCES CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Resources Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| ANTERO RESOURCES CORPORATION | June 3, 2026 | To ratify the appointment of KPMG LLP as Antero Resources Corporation's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
Split 3 FOR, 5 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Authorize the Board or the Audit Committee of the Board to determine the remuneration of Ernst & Young Ireland, in its capacity as the Company's statutory auditor under Irish Law. Audit-related |
Board | For | FOR 9 funds |
Split 9 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Authorize the Board to issue Class A Ordinary Shares under Irish Law. Capital Structure |
Board | For | FOR 9 funds |
Split 9 FOR, 2 AGAINST |
| AON PLC | June 26, 2026 | Authorize the Board to opt-out of statutory pre-emption rights under Irish Law. Capital Structure |
Board | For | FOR 9 funds |
Split 9 FOR, 2 AGAINST |
| AON PLC | June 26, 2026 | Election of Directors: Adriana Karaboutis Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Byron O. Spruell Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Cheryl A. Francis Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Gloria Santona Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Gregory C. Case Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: James G. Stavridis Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jeffrey C. Campbell Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jin-Yong Cai Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jo Ann Jenkins Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jose Antonio Alvarez Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Lester B. Knight Director Elections |
Board | For | FOR 9 funds |
Split 7 FOR, 1 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Richard C. Notebaert Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Sarah E. Smith Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Re-appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish Law. Audit-related |
Board | For | FOR 9 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | FOR 9 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Approval of an amendment to APA's 2016 Omnibus Compensation Plan to extend its term and increase the shares authorized for issuance thereunder Compensation |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Annell R. Bay Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Anya Weaving Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Chansoo Joung Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Charles W. Hooper Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: David L. Stover Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: H. Lamar McKay Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: John J. Christmann IV Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Juliet S. Ellis Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Kenneth M. Fisher Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Peter A. Ragauss Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Ratification of appointment of Ernst & Young LLP as APA's independent auditor Audit-related |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 9 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 6 funds |
Split 9 FOR, 2 ABSTAIN |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 5 funds |
Split 6 FOR, 3 ABSTAIN |
← Previous Page 13 of 111 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.